Dr. Karen E. Hoffman
Claim this profileM D Anderson Cancer Center
Studies Prostate Cancer
Studies Breast Cancer
5 reported clinical trials
18 drugs studied
Area of expertise
1Prostate Cancer
2Breast Cancer
Stage II
Stage III
Stage I
Affiliated Hospitals
Clinical Trials Karen E. Hoffman is currently running
Hormone + Radiation Therapy
for Prostate Cancer
This phase III trial compares less intense hormone therapy and radiation therapy to usual hormone therapy and radiation therapy in treating patients with high risk prostate cancer and low gene risk score. This trial also compares more intense hormone therapy and radiation therapy to usual hormone therapy and radiation therapy in patients with high risk prostate cancer and high gene risk score. Apalutamide may help fight prostate cancer by blocking the use of androgen by the tumor cells. Radiation therapy uses high energy rays to kill tumor cells and shrink tumors. Giving a shorter hormone therapy treatment may work the same at controlling prostate cancer compared to the usual 24 month hormone therapy treatment in patients with low gene risk score. Adding apalutamide to the usual treatment may increase the length of time without prostate cancer spreading as compared to the usual treatment in patients with high gene risk score.
Recruiting2 awards Phase 36 criteria
Shorter vs Usual Radiation Therapy
for Prostate Cancer
This phase III trial compares stereotactic body radiation therapy (SBRT), (five treatments over two weeks using a higher dose per treatment) to usual radiation therapy (20 to 45 treatments over 4 to 9 weeks) for the treatment of high-risk prostate cancer. SBRT uses special equipment to position a patient and deliver radiation to tumors with high precision. This method may kill tumor cells with fewer doses over a shorter period of time. This trial is evaluating if shorter duration radiation prevents cancer from coming back as well as the usual radiation treatment.
Recruiting2 awards Phase 310 criteria
More about Karen E. Hoffman
Clinical Trial Related8 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Karen E. Hoffman has experience with
- Apalutamide
- Radiation Therapy
- Androgen Deprivation Therapy
- Hypofractionated Radiation Therapy
- Photon
- Proton
Breakdown of trials Karen E. Hoffman has run
Prostate Cancer
Breast Cancer
Prostate Adenocarcinoma
Visual Impairment
Hormone Therapy
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Karen E. Hoffman specialize in?
Karen E. Hoffman focuses on Prostate Cancer and Breast Cancer. In particular, much of their work with Prostate Cancer has involved treating patients, or patients who are undergoing treatment.
Is Karen E. Hoffman currently recruiting for clinical trials?
Yes, Karen E. Hoffman is currently recruiting for 3 clinical trials in Houston Texas. If you're interested in participating, you should apply.
Are there any treatments that Karen E. Hoffman has studied deeply?
Yes, Karen E. Hoffman has studied treatments such as Apalutamide, Radiation Therapy, Androgen Deprivation Therapy.
What is the best way to schedule an appointment with Karen E. Hoffman?
Apply for one of the trials that Karen E. Hoffman is conducting.
What is the office address of Karen E. Hoffman?
The office of Karen E. Hoffman is located at: M D Anderson Cancer Center, Houston, Texas 77030 United States. This is the address for their practice at the M D Anderson Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.